ASMB (Assembly Biosciences) 3-1 Month Momentum %: -21.63% (As of Jul. 07, 2026)


ASMB Assembly Biosciences Inc ASMB
31 GF Score
Price $29.29
! 3 Warning Signs
View Full Analysis

What is Assembly Biosciences 3-1 Month Momentum %?

Assembly Biosciences ASMB +1.09% 31 3-1 Month Momentum % is -21.63% as of Jul. 07, 2026. GuruFocus rates ASMB with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 1,375 Biotechnology companies, Assembly Biosciences ranks worse than 74.04% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-07), Assembly Biosciences's 3-1 Month Momentum % is -21.63%.

The industry rank for Assembly Biosciences's 3-1 Month Momentum % or its related term are showing as below:

ASMB's 3-1 Month Momentum % is ranked worse than
74.04% of 1375 companies
in the Biotechnology industry
Industry Median: -8.46 vs ASMB: -21.63

Assembly Biosciences  (NAS:ASMB) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Assembly Biosciences 3-1 Month Momentum % Related Terms

ASMB vs CTNM, PRTA, RGNX: 3-1 Month Momentum % Comparison

For the Biotechnology subindustry, Assembly Biosciences's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Assembly Biosciences 3-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Assembly Biosciences's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Assembly Biosciences's 3-1 Month Momentum % falls into.


ASMB
31GF Score
Assembly Biosciences Inc ASMB
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Assembly Biosciences  (NAS:ASMB) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -21.63% mean?
Assembly Biosciences (ASMB) has a 3-1 Month Momentum % of -21.63% as of Jul. 07, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Assembly Biosciences and its competitors. According to the industry distribution chart, Assembly Biosciences ranks #1018 out of 1375 companies in the Biotechnology industry, placing it in the top 74%.
Is Assembly Biosciences' 3-1 Month Momentum % too high?
Assembly Biosciences' current 3-1 Month Momentum % is -21.63%. Based on the distribution chart, Assembly Biosciences ranks #1018 out of 1375 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Assembly Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Assembly Biosciences' 3-1 Month Momentum % compare to CTNM and PRTA?
According to the Biotechnology industry distribution chart, Assembly Biosciences ranks #1018 out of 1375 companies for 3-1 Month Momentum %. This places Assembly Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Assembly Biosciences and its competitors. Assembly Biosciences's current 3-1 Month Momentum % is -21.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Assembly Biosciences stock overvalued right now?
Assembly Biosciences (ASMB) has a current 3-1 Month Momentum % of -21.63%. The current 3-1 Month Momentum % is -21.63%. Assembly Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Assembly Biosciences (ASMB), the current 3-1 Month Momentum % is -21.63% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Assembly Biosciences Business Description

Other Exchanges V7B:Germany
Address Two Tower Place, 7th Floor, South San Francisco, CA, USA, 94080
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
31GF Score

Get the complete analysis for ASMB

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.29
Price